| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1021069U |
| P356 | DOI | 10.1371/JOURNAL.PONE.0121069 |
| P932 | PMC publication ID | 4373845 |
| P698 | PubMed publication ID | 25807532 |
| P5875 | ResearchGate publication ID | 274081054 |
| P50 | author | Francisco Altamirano | Q43078274 |
| P2093 | author name string | Jose R Lopez | |
| Arkady Uryash | |||
| Jorge Bassuk | |||
| Jose A Adams | |||
| Paul Kurlansky | |||
| P2860 | cites work | Na⁺ transport in the normal and failing heart - remember the balance | Q24338863 |
| Signaling effectors underlying pathologic growth and remodeling of the heart | Q26825154 | ||
| Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
| Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice | Q30444848 | ||
| Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction | Q33331962 | ||
| Recognizing pain and distress in laboratory animals | Q34220321 | ||
| Defining the moribund condition as an experimental endpoint for animal research | Q34282740 | ||
| A systematic approach for establishing humane endpoints | Q34282747 | ||
| Regulation of the cardiac Na⁺/H⁺ exchanger in health and disease | Q34328953 | ||
| Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction | Q34584267 | ||
| A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species | Q34699668 | ||
| Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. | Q34761461 | ||
| A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling | Q34871542 | ||
| Nitric oxide and cardioprotection during ischemia-reperfusion | Q34963358 | ||
| Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis | Q35090049 | ||
| Nitric oxide and cardiovascular protection | Q35090355 | ||
| Nitric oxide and excitation-contraction coupling | Q35159059 | ||
| Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. | Q35636526 | ||
| Nitric oxide in myocardial ischemia/reperfusion injury | Q35666882 | ||
| Peak longitudinal strain most accurately reflects myocardial segmental viability following acute myocardial infarction - an experimental study in open-chest pigs | Q36116447 | ||
| Cardiac genomic response following preconditioning stimulus | Q36432916 | ||
| Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation | Q36652837 | ||
| Left and right ventricle late remodeling following myocardial infarction in rats. | Q36891606 | ||
| Heart failure epidemiology: European perspective | Q36928514 | ||
| Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling | Q37002262 | ||
| The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone | Q37232163 | ||
| Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling | Q37263689 | ||
| The role of nitric oxide in myocardial repair and remodeling | Q37388623 | ||
| Cardiac sodium-calcium exchange and efficient excitation-contraction coupling: implications for heart disease | Q37520074 | ||
| Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association | Q37538031 | ||
| eNOS phosphorylation in health and disease. | Q37723790 | ||
| Na/Ca exchange and contraction of the heart. | Q38114737 | ||
| Effect of moderate-intensity exercise, whole-body periodic acceleration, and passive cycling on nitric oxide release into circulation | Q39733711 | ||
| Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines | Q40783492 | ||
| Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats | Q42142166 | ||
| In vivo upregulation of nitric oxide synthases in healthy rats | Q42802889 | ||
| Myocardial expression of PDECGF is associated with extracellular matrix remodeling in experimental myocardial infarction in rats | Q43016314 | ||
| "Passive exercise" using whole body periodic acceleration: effects on coronary microcirculation | Q43110692 | ||
| Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning | Q43138774 | ||
| Regional blood flow during periodic acceleration | Q43757748 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q43926534 | ||
| Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation | Q43933105 | ||
| Calcium-induced damage of rat heart mitochondria | Q44086997 | ||
| Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Coun | Q44118018 | ||
| Chronic intermittent hypobaric hypoxia ameliorates ischemia/reperfusion-induced calcium overload in heart via Na/Ca2+ exchanger in developing rats | Q44134506 | ||
| Effects of periodic body acceleration on the in vivo vasoactive response to N-omega-nitro-L-arginine and the in vitro nitric oxide production | Q44753234 | ||
| Heart failure after myocardial infarction: altered excitation-contraction coupling. | Q44922189 | ||
| Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors | Q45121967 | ||
| Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups | Q45381644 | ||
| Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy. | Q45873510 | ||
| Low-amplitude pulses to the circulation through periodic acceleration induces endothelial-dependent vasodilatation | Q46072857 | ||
| N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster. | Q46456172 | ||
| Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells | Q46612384 | ||
| Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction | Q46628006 | ||
| Aerobic interval training attenuates remodelling and mitochondrial dysfunction in the post-infarction failing rat heart | Q46894479 | ||
| Humane endpoints in shock research | Q47318593 | ||
| Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat | Q47319740 | ||
| Effect on treadmill exercise capacity, myocardial ischemia, and left ventricular function as a result of repeated whole-body periodic acceleration with heparin pretreatment in patients with angina pectoris and mild left ventricular dysfunction | Q48952343 | ||
| Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging | Q50470562 | ||
| Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? | Q51789753 | ||
| Adrenomedullin is increased by pulsatile shear stress on the vascular endothelium via periodic acceleration (pGz). | Q51970693 | ||
| Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. | Q53537606 | ||
| Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats. | Q53918654 | ||
| Preconditioning with periodic acceleration (pGz) provides second window of cardioprotection. | Q54497830 | ||
| Mild exercise training, cardioprotection and stress genes profile. | Q54563988 | ||
| Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. | Q54705304 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q59091659 | ||
| Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels | Q64378155 | ||
| Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease | Q67257157 | ||
| Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow | Q67924397 | ||
| Expression of inducible nitric oxide synthase in human heart failure | Q71129305 | ||
| Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion | Q73166881 | ||
| Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction | Q73733133 | ||
| Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction | Q73789305 | ||
| Abnormal myocyte Ca2+ homeostasis in rabbits with pacing-induced heart failure | Q77328126 | ||
| Exercise-induced and nitroglycerin-induced myocardial preconditioning improves hemodynamics in patients with angina | Q79768733 | ||
| Periodic whole body acceleration: a novel therapy for cardiovascular disease | Q80929692 | ||
| TNFalpha in myocardial ischemia/reperfusion: damage vs. protection | Q82283700 | ||
| Periodic acceleration (pGz) acutely increases endothelial and neuronal nitric oxide synthase expression in endomyocardium of normal swine | Q82674902 | ||
| Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: a gated SPECT imaging study | Q85030549 | ||
| Cross-talking. Ca2+, H+ and nitric oxide | Q87489229 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0121069 | |
| P577 | publication date | 2015-03-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz). | |
| P478 | volume | 10 |
| Q27303654 | Antioxidant Properties of Whole Body Periodic Acceleration (pGz) |
| Q51790348 | Exercise Exerts Its Beneficial Effects on Acute Coronary Syndrome: Clinical Evidence. |
| Q46041606 | Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency |
| Q61809737 | Whole body periodic acceleration improves survival and microvascular leak in a murine endotoxin model |
Search more.